Publications: Al Shamaileh, Hadi

Journal Article

Yin, W., Pham, C.V., Wang, T., Al Shamaileh, H., Chowdhury, R., Patel, S., Li, Y., Kong, L., Hou, Y., Zhu, Y., Chen, S., Xu, H., Jia, L., Duan, W. and Xiang, D. (2022) Inhibition of autophagy promotes the elimination of liver cancer stem cells by CD133 aptamer-targeted delivery of doxorubicin. Biomolecules, 12 (11). Article 1623.

Chakravarthy, M., Al Shamaileh, H., Huang, H., Tannenberg, R.K., Chen, S., Worrall, S., Dodd, P.R. and Veedu, R.N. (2018) Development of DNA aptamers targeting low-molecular-weight amyloid-β peptide aggregates in vitro. Chemical Communications, 54 (36). pp. 4593-4596.

Al Shamaileh, H. and Veedu, R.N. (2017) Next-Generation Nucleic Acid Aptamers with Two-Base-Modified Nucleotides Have Improved Binding Affinity and Potency. ChemBioChem, 18 (16). pp. 1565-1567.

Al Shamaileh, H., Wang, T., Xiang, D., Yin, W., Tran, P.H-L, Barrero, R.A., Zhang, P-Z, Li, Y., Kong, L., Liu, K., Zhou, S-F, Hou, Y., Shigdar, S. and Duan, W. (2017) Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells. Scientific Reports, 7 (1).

Rahimizadeh, K., Al Shamaileh, H., Fratini, M., Chakravarthy, M., Stephen, M., Shigdar, S. and Veedu, R. (2017) Development of Cell-Specific aptamers: Recent advances and insight into the selection procedures. Molecules, 22 (12). p. 2070.